COMMUNIQUÉS West-GlobeNewswire

Corvus Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
20/01/2026
SOUTH SAN FRANCISCO, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today announced that it has commenced an underwritten public [...]
Clearmind Medicine Inc. Files Annual Report on Form 20-F for the Fiscal Year Ended October 31, 2025
20/01/2026
Vancouver, Canada, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel [...]
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
20/01/2026
SOUTH SAN FRANCISCO, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on January 15, 2026 it granted stock options to purchase an aggregate of 29,416 shares of [...]
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds
20/01/2026
LITTLETON, Colo., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (Nasdaq: VVOS), a leading medical device and healthcare services company focused on sleep related breathing [...]
BioAge Announces Proposed Public Offering
20/01/2026
EMERYVILLE, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (Nasdaq: BIOA) (“BioAge”, “the Company”), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic [...]
Protext Mobility, Inc. (OTC: TXTM) is thrilled to share a transformative update, advancing uplisting readiness with a preliminary Deloitte engagement
20/01/2026
FORT LAUDERDALE, Fla., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Protext Mobility, Inc. (OTC: TXTM) (“Protext” “TXTM” or the “Company”) is thrilled to share a transformative update that underscores its strategic execution, [...]
Bacterial Mechanism That Could Help Prevent and Treat Lyme Arthritis Identified by New Bay Area Lyme Foundation–Supported Study
20/01/2026
Research published in PLOS Pathogens highlights a cell wall–driven trigger of joint inflammation, pointing to new ways to target Lyme arthritis PORTOLA VALLEY, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Bay Area Lyme [...]
Gold medal winner at SIVAL, Amoéba displays its ambitions for its biocontrol solution
20/01/2026
Chassieu, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Chassieu (France), 20 January 2026 – 6:00 pm - Amoéba (FR0011051598 - ALMIB) , industrial greentech specialised in the development of natural microbiological solutions based [...]
Vitalic Health, powered by HFMA, launches U.S. Healthcare Vitals Tracker to measure affordability, financial sustainability and health outcomes
20/01/2026
CHICAGO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association’s Vitalic Health today released the U.S. Vitals Tracker, a first-of-its-kind tool that measures the health of U.S. healthcare. [...]
Informations relatives au nombre total de droits de vote et d’actions composant le capital
20/01/2026
Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes, le 20 janvier 2026 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement [...]
Half-Year Report on Liquidity Contract with Invest Securities
20/01/2026
Half-Year Report on Liquidity Contract with Invest Securities NANTES, France - January 20, 2026, 6:00pm CET – Under the liquidity contract entrusted by OSE Immunotherapeutics to Invest Securities, the following [...]
First-of-its-kind Trojan Horse Cancer Treatment Approved for Clinical Trials
20/01/2026
Peptinovo Biopharma’s Targeted Cancer Drug Platform Moves to Human Trials in Australia ANN ARBOR, Mich., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Peptinovo Biopharma, an Ann Arbor–based biotechnology company pioneering [...]
Rentschler Biopharma Announces Executive Board Changes and Next Phase of Corporate Strategy
20/01/2026
Company implements next growth stage following successful strategic and operational development Uwe Buecheler, PhD, Vice Chairman of the Supervisory Board, appointed interim CEO LAUPHEIM, Germany and MILFORD, Mass., Jan [...]
Orphai Therapeutics’ Phase 2a LAM-001 Study Selected for Oral Presentation at the American Thoracic Society (ATS) 2026 International Conference
20/01/2026
NEW HAVEN, Conn., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Orphai Therapeutics Inc. (“Orphai”) , a clinical-stage biopharmaceutical company dedicated to advancing novel therapeutics for patients with diseases of significant [...]
New Research Reveals Key Quality of Life Insights in ADHD Management
20/01/2026
Qbtech research analyzing nearly 1,000 patients found a correlation between objective ADHD performance and meaningful changes in daily functioning and well-being HOUSTON, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Qbtech , a [...]
CARBIOS : Bilan semestriel du contrat de liquidité confié à Natixis ODDO BHF et annonce de sa suspension
20/01/2026
Titre concerné : CARBIOS (code ISIN FR0011648716) Marché concerné : Euronext Growth Paris Clermont-Ferrand (France), le 20 janvier 2026 (18h00 CET). CARBIOS présente le bilan semestriel du contrat de liquidité conclu [...]
Next-Generation Healthcare Provider ONTO Health Names Dr. Roohi Jeelani Founder & CEO, Expands to Chicago and the Midwest
20/01/2026
ONTO Health is advancing a more comprehensive, human-centered approach to healthcare, supporting health and well-being across the lifespan Chicago, Jan. 20, 2026 (GLOBE NEWSWIRE) -- ONTO Health , a next-generation [...]
Tiziana Life Sciences Announces the Peer-Reviewed Publication of Clinical Study Results for Intranasal Foralumab
20/01/2026
BOSTON, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody [...]
Cosmos Health Announces Accelerating Customer Growth, Improving Unit Economics and Robotic Expansion Supporting $40M in Additional Annual Revenue
20/01/2026
CHICAGO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced continued operational growth [...]

Pages